Author/Authors :
Mozafari ، M. Australasian Nanoscience and Nanotechnology Initiative (ANNI) - Monash University LPO , Alavi ، Mehran Department of Biological Science Nanobiotechnology Department - Faculty of Science - University of Kurdistan
Abstract :
Some of the currently available encapsulation systems, including liposomes, nanoliposomes, and solid lipid nanoparticles, have already been approved to be used in the pharmaceutical, food, textile, and cosmetic markets. These systems have proven to be useful for the encapsulation, controlled release, targeting drugs, vaccines (including Covid-19 vaccines), and other bioactive compounds in vitro and in vivo. The most recently invented encapsulation system, known as tocosome , is formulated employing two derivatives of alpha-tocopherol (vitamin E). Although tocosomes are somehow similar to lipid vesicles, they possess exceptional characteristics mainly due to the presence of unique ingredients in their structures. There have been ambiguities in the scientific literature regarding the differences between tocosomes, liposomes, and nanoliposomes. The present article aims to provide brief scientific explanations in a clear way to highlight differences between the mentioned drug carriers.
Keywords :
Alpha tocopherol , Tocosome , Liposome , Nanoliposome , Drug Delivery , Encapsulation